MARIA DOLORES
CHIARA ROMERO
Investigador/a
Hospital Universitario Central de Asturias
Oviedo, EspañaPublicacións en colaboración con investigadores/as de Hospital Universitario Central de Asturias (34)
2024
2023
-
Exploratory Analysis of the Gene Expression Matrix Based on Dual Conditional Dimensionality Reduction
IEEE Journal of Biomedical and Health Informatics, Vol. 27, Núm. 6, pp. 3083-3092
-
Visualizing Cell Motility Patterns from Time Lapse Videos with Interactive 2D Maps Generated with Deep Autoencoders
IFIP Advances in Information and Communication Technology
2022
-
Differential HIF2α Protein Expression in Human Carotid Body and Adrenal Medulla under Physiologic and Tumorigenic Conditions
Cancers, Vol. 14, Núm. 12
-
Interactive visual analytics for medical data: application to COVID-19 clinical information during the first wave
ESANN 2022 proceedings. European Symposium on Artificial Neural Networks, Computational Intelligence and Machine Learning
2021
-
Morphing projections: a new visual technique for fast and interactive large-scale analysis of biomedical datasets
Bioinformatics (Oxford, England), Vol. 37, Núm. 11, pp. 1571-1580
2020
-
Epigenetic downregulation of TET3 reduces genome-wide 5hmC levels and promotes glioblastoma tumorigenesis
International Journal of Cancer, Vol. 146, Núm. 2, pp. 373-387
-
The Leader Position of Mesenchymal Cells Expressing N-Cadherin in the Collective Migration of Epithelial Cancer
Cells, Vol. 9, Núm. 3
2019
-
Chromatin regulation by Histone H4 acetylation at Lysine 16 during cell death and differentiation in the myeloid compartment
Nucleic Acids Research, Vol. 47, Núm. 10, pp. 5016-5037
-
Clinical significance and peculiarities of succinate dehydrogenase B and hypoxia inducible factor 1α expression in parasympathetic versus sympathetic paragangliomas
Head and Neck, Vol. 41, Núm. 1, pp. 79-91
-
Epigenetic Deregulation of Protocadherin PCDHGC3 in Pheochromocytomas/Paragangliomas Associated With SDHB Mutations
The Journal of clinical endocrinology and metabolism, Vol. 104, Núm. 11, pp. 5673-5692
2018
-
Epigenetic dysregulation of TET2 in human glioblastoma
Oncotarget, Vol. 9, Núm. 40, pp. 25922-25934
-
SDHC promoter methylation, a novel pathogenic mechanism in parasympathetic paragangliomas
Journal of Clinical Endocrinology and Metabolism, Vol. 103, Núm. 1, pp. 295-305
2017
-
Clinically relevant HIF-1α-dependent metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the miR-210/ISCU signaling axis, but not MCT1 and MCT4 upregulation
Oncotarget, Vol. 8, Núm. 8, pp. 13730-13746
-
Control of long-distance cell-to-cell communication and autophagosome transfer in squamous cell carcinoma via tunneling nanotubes
Oncotarget, Vol. 8, Núm. 13, pp. 20939-20960
-
Role of VHL, HIF1A and SDH on the expression of miR-210: Implications for tumoral pseudo-hypoxic fate
Oncotarget, Vol. 8, Núm. 4, pp. 6700-6717
2016
-
Berkelic Acid: Straightforward Analogue Synthesis and Studies of Activity Against Selected Cancer Cell Lines
European Journal of Organic Chemistry, Vol. 2016, Núm. 35, pp. 5876-5880
2015
-
Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma
Oral Diseases, Vol. 21, Núm. 7, pp. 899-904
-
In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growth factor receptor therapy
Head and Neck, Vol. 37, Núm. 8, pp. 1150-1162
-
PARD3 inactivation in lung squamous cell carcinomas impairs STAT3 and promotes malignant invasion
Cancer Research, Vol. 75, Núm. 7, pp. 1287-1297